Back to Journals » Advances and Applications in Bioinformatics and Chemistry » Volume 3

A kinetic platform for in silico modeling of the metabolic dynamics in Escherichia coli

Authors Barve A, Gupta A, Solapure S, Kumar A, Ramachandran V, Seshadri K, Vali S, Datta S

Published 7 December 2010 Volume 2010:3 Pages 97—110

DOI https://doi.org/10.2147/AABC.S14368

Review by Single-blind

Peer reviewer comments 2

Aditya Barve1, Anvita Gupta2, Suresh M Solapure2, Ansu Kumar1, Vasanthi Ramachandran2, Kothandaraman Seshadri2, Shireen Vali1, Santanu Datta2
1Cellworks Research India Pvt. Ltd, Bangalore, India; 2AstraZeneca, Bangalore, India

Background: A prerequisite for a successful design and discovery of an antibacterial drug is the identification of essential targets as well as potent inhibitors that adversely affect the survival of bacteria. In order to understand how intracellular perturbations occur due to inhibition of essential metabolic pathways, we have built, through the use of ordinary differential equations, a mathematical model of 8 major Escherichia coli pathways.
Results: Individual in vitro enzyme kinetic parameters published in the literature were used to build the network of pathways in such a way that the flux distribution matched that reported from whole cells. Gene regulation at the transcription level as well as feedback regulation of enzyme activity was incorporated as reported in the literature. The unknown kinetic parameters were estimated by trial and error through simulations by observing network stability. Metabolites, whose biosynthetic pathways were not represented in this platform, were provided at a fixed concentration. Unutilized products were maintained at a fixed concentration by removing excess quantities from the platform. This approach enabled us to achieve steady state levels of all the metabolites in the cell. The output of various simulations correlated well with those previously published.
Conclusion: Such a virtual platform can be exploited for target identification through assessment of their vulnerability, desirable mode of target enzyme inhibition, and metabolite profiling to ascribe mechanism of action following a specific target inhibition. Vulnerability of targets in the biosynthetic pathway of coenzyme A was evaluated using this platform. In addition, we also report the utility of this platform in understanding the impact of a physiologically relevant carbon source, glucose versus acetate, on metabolite profiles of bacterial pathogens.

Keywords: antibacterial drug, mathematical model, kinetic platform, metabolic dynamics, Escherichia coli

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]